Assenagon Asset Management S.A. Acquires Shares of 279,972 Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Assenagon Asset Management S.A. bought a new position in Establishment Labs Holdings Inc. (NASDAQ:ESTA) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 279,972 shares of the company’s stock, valued at approximately $12,898,000. Assenagon Asset Management S.A. owned 1.00% of Establishment Labs as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Sei Investments Co. boosted its stake in shares of Establishment Labs by 634.5% in the second quarter. Sei Investments Co. now owns 40,576 shares of the company’s stock valued at $1,844,000 after buying an additional 35,052 shares in the last quarter. Nkcfo LLC acquired a new stake in Establishment Labs in the second quarter valued at $227,000. Hood River Capital Management LLC purchased a new stake in shares of Establishment Labs during the 2nd quarter worth $43,000. Affinity Asset Advisors LLC grew its stake in shares of Establishment Labs by 4.1% during the 2nd quarter. Affinity Asset Advisors LLC now owns 223,407 shares of the company’s stock worth $10,152,000 after purchasing an additional 8,818 shares during the period. Finally, Millennium Management LLC increased its holdings in shares of Establishment Labs by 49.8% in the 2nd quarter. Millennium Management LLC now owns 273,605 shares of the company’s stock valued at $12,433,000 after purchasing an additional 90,943 shares in the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on ESTA. BTIG Research increased their target price on shares of Establishment Labs from $62.00 to $65.00 and gave the company a “buy” rating in a report on Monday, October 14th. Stephens raised Establishment Labs to a “strong-buy” rating in a report on Monday, December 2nd. Finally, Citigroup upped their target price on Establishment Labs from $45.00 to $50.00 and gave the company a “neutral” rating in a report on Tuesday, October 1st. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $60.60.

Establishment Labs Price Performance

ESTA stock opened at $34.56 on Friday. The stock’s 50 day moving average price is $42.96 and its 200 day moving average price is $43.42. The firm has a market cap of $967.68 million, a P/E ratio of -13.40 and a beta of 1.15. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. Establishment Labs Holdings Inc. has a 1 year low of $30.20 and a 1 year high of $60.12.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.